These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18274730)

  • 1. Imaging apomorphine stimulation of brain arachidonic acid signaling via D2-like receptors in unanesthetized rats.
    Bhattacharjee AK; Chang L; White L; Bazinet RP; Rapoport SI
    Psychopharmacology (Berl); 2008 May; 197(4):557-66. PubMed ID: 18274730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-Amphetamine stimulates D2 dopamine receptor-mediated brain signaling involving arachidonic acid in unanesthetized rats.
    Bhattacharjee AK; Chang L; White L; Bazinet RP; Rapoport SI
    J Cereb Blood Flow Metab; 2006 Nov; 26(11):1378-88. PubMed ID: 16511499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D2 but not D1 dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats.
    Bhattacharjee AK; Chang L; Lee HJ; Bazinet RP; Seemann R; Rapoport SI
    Psychopharmacology (Berl); 2005 Aug; 180(4):735-42. PubMed ID: 16163535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid.
    Basselin M; Chang L; Bell JM; Rapoport SI
    Neuropsychopharmacology; 2005 Jun; 30(6):1064-75. PubMed ID: 15812572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic carbamazepine administration attenuates dopamine D2-like receptor-initiated signaling via arachidonic acid in rat brain.
    Basselin M; Chang L; Chen M; Bell JM; Rapoport SI
    Neurochem Res; 2008 Jul; 33(7):1373-83. PubMed ID: 18302021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats.
    Ramadan E; Basselin M; Taha AY; Cheon Y; Chang L; Chen M; Rapoport SI
    Neuropharmacology; 2011 Dec; 61(8):1256-64. PubMed ID: 21839100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic d-amphetamine depresses an imaging marker of arachidonic acid metabolism in rat brain.
    Bhattacharjee AK; Chang L; Chen M; White L; Bell JM; Bazinet RP; Rapoport SI
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):957-69. PubMed ID: 18570702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
    Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
    Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo imaging of disturbed pre- and post-synaptic dopaminergic signaling via arachidonic acid in a rat model of Parkinson's disease.
    Bhattacharjee AK; Meister LM; Chang L; Bazinet RP; White L; Rapoport SI
    Neuroimage; 2007 Oct; 37(4):1112-21. PubMed ID: 17681816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective dopamine receptor stimulation differentially affects [3H]arachidonic acid incorporation, a surrogate marker for phospholipase A2-mediated neurotransmitter signal transduction, in a rodent model of Parkinson's disease.
    Hayakawa T; Chang MC; Rapoport SI; Appel NM
    J Pharmacol Exp Ther; 2001 Mar; 296(3):1074-84. PubMed ID: 11181943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased dopamine D2 receptor binding and enhanced apomorphine-induced locomotor activity in mu-opioid receptor knockout mice.
    Tien LT; Park Y; Fan LW; Ma T; Loh HH; Ho IK
    Brain Res Bull; 2003 Jun; 61(1):109-15. PubMed ID: 12788214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
    Flores-Tochihuitl J; Vargas G; Morales-Medina JC; Rivera G; De La Cruz F; Zamudio S; Flores G
    Synapse; 2008 Jan; 62(1):40-9. PubMed ID: 17957737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral effects of dopamine agonists and antagonists in MPTP-lesioned D3 receptor knockout mice.
    Yarkov AV; Hanger D; Reploge M; Joyce JN
    Pharmacol Biochem Behav; 2003 Dec; 76(3-4):551-62. PubMed ID: 14643855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of (11)C-arachidonate PET to study in vivo dopaminergic neurotransmission in humans.
    Thambisetty M; Gallardo KA; Liow JS; Beason-Held LL; Umhau JC; Bhattacharjee AK; Der M; Herscovitch P; Rapoport JL; Rapoport SI
    J Cereb Blood Flow Metab; 2012 Apr; 32(4):676-84. PubMed ID: 22167235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
    Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
    Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
    Sóvágó J; Makkai B; Gulyás B; Hall H
    Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.
    Newman-Tancredi A; Cussac D; Brocco M; Rivet JM; Chaput C; Touzard M; Pasteau V; Millan MJ
    Brain Res; 2001 Nov; 920(1-2):41-54. PubMed ID: 11716810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knocking out the dopamine reuptake transporter (DAT) does not change the baseline brain arachidonic acid signal in the mouse.
    Ramadan E; Chang L; Chen M; Ma K; Hall FS; Uhl GR; Rapoport SI; Basselin M
    Int J Neurosci; 2012 Jul; 122(7):373-80. PubMed ID: 22376027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M; Dekeyne A; Papp M; Millan MJ
    Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Yates TM
    Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.